Literature DB >> 17505163

Healing of chronic necrobiosis lipoidica lesions in a type 1 diabetic patient after pancreas-kidney transplantation: a case report.

D Gullo1, A Latina, L Tomaselli, M L Arpi, S Squatrito, S Curatolo, S La Greca, R Vigneri.   

Abstract

Necrobiosis lipoidica (NL) is a degenerative disease of dermal connective tissue of unknown etiology characterized by erythematous plaques preferentially localized to distal extremities. Skin lesions show a chronic relapsing nature. NL is often associated with diabetes mellitus and satisfactory treatment options are lacking. We describe the spontaneous healing of NL lesions after pancreas and kidney transplantation in a Type 1 diabetic patient with chronic NL recalcitrant to a variety of standard treatments. The 31-yr-old male patient had experienced NL lesions for more than 15 yr; despite various systemic and topical treatments, the skin lesions had pregressively enlarged. Because of end-stage renal disease, a simultaneous pancreas and kidney transplantation was performed and immunosuppressive therapy with tacrolimus (TAC), mycophenolate mofetil (MMF), and prednisone was started. Pancreatic transplantation maintained satisfactory metabolic control with no need of exogenous insulin. After transplantation, skin lesions slowly healed without any specific treatment, leaving residual areas of fibrotic scars. A skin biopsy confirmed the absence of typical NL lymphocytic and histiocytic inflammatory response. Clinical remission of NL lesions may probably be explained by the concomitant effect of multiple-drug regimen for immunosuppression (TAC, MMF, and prednisone) and improved skin microcirculation secondary to the good metabolic control provided by pancreas transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17505163     DOI: 10.1007/BF03347436

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Successful treatment of ulcerated necrobiosis lipoidica with mycophenolate mofetil.

Authors:  G Reinhard; F Lohmann; M Uerlich; R Bauer; T Bieber
Journal:  Acta Derm Venereol       Date:  2000 Jul-Aug       Impact factor: 4.437

2.  Topical tacrolimus in granuloma annulare and necrobiosis lipoidica.

Authors:  W Harth; R Linse
Journal:  Br J Dermatol       Date:  2004-04       Impact factor: 9.302

3.  Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment.

Authors:  T H Clayton; P V Harrison
Journal:  Br J Dermatol       Date:  2005-03       Impact factor: 9.302

4.  A case of necrobiosis lipoidica treated with systemic corticosteroid.

Authors:  Y Taniguchi; T Sakamoto; M Shimizu
Journal:  J Dermatol       Date:  1993-05       Impact factor: 4.005

5.  Necrobiosis lipoidica: treatment with systemic corticosteroids.

Authors:  P Petzelbauer; K Wolff; G Tappeiner
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

6.  Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients.

Authors:  Paolo Fiorina; Franco Folli; Federico Bertuzzi; Paola Maffi; Giovanna Finzi; Massimo Venturini; Carlo Socci; Alberto Davalli; Elena Orsenigo; Lucilla Monti; Luca Falqui; Silvia Uccella; Stefano La Rosa; Luciana Usellini; Giuliana Properzi; Valerio Di Carlo; Alessandro Del Maschio; Carlo Capella; Antonio Secchi
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

7.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Authors:  E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

Review 8.  Manifestations of cutaneous diabetic microangiopathy.

Authors:  Binh T Ngo; Kristie D Hayes; Dominick J DiMiao; Shashi K Srinivasan; Christopher J Huerter; Marc S Rendell
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

9.  Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline.

Authors:  K C Noz; M J Korstanje; B J Vermeer
Journal:  Clin Exp Dermatol       Date:  1993-01       Impact factor: 3.470

Review 10.  Necrobiosis lipoidica and diabetic control revisited.

Authors:  O Cohen; R Yaniv; A Karasik; H Trau
Journal:  Med Hypotheses       Date:  1996-04       Impact factor: 1.538

View more
  2 in total

1.  [Topical tacrolimus in necrobiosis lipoidica].

Authors:  D Barth; W Harth; R Treudler; J C Simon
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

Review 2.  Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.

Authors:  Amir Feily; Shadi Mehraban
Journal:  Dermatol Reports       Date:  2015-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.